Percheron Therapeutics LimitedASX: PER

US FDA Type C Meeting for ATL1102 in DMD

Apr 23, 2021 at 4:12 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment